Glancy Prongay Wolke & Rotter LLP, a national shareholder rights law firm, announced a securities fraud investigation into InMode Ltd. (NASDAQ: INMD) on July 2, 2026, concerning possible violations of federal securities laws.
"Companies that misrepresent their financial condition or business prospects can face significant legal consequences," a representative of the law firm said. "We are investigating whether InMode made false or misleading statements to investors."
The investigation follows an event on June 30, 2026, that triggered the law firm's review of InMode's disclosures. InMode, a medical technology company specializing in minimally invasive aesthetic solutions, has not yet commented on the probe.
The investigation creates legal overhang for InMode and could lead to shareholder lawsuits, regulatory penalties, and reputational damage. Investors who purchased InMode securities and suffered losses are urged to contact the law firm to discuss their legal rights. The outcome of the investigation will determine whether the company faces formal securities fraud litigation.
This article is for informational purposes only and does not constitute investment advice.